Modera Wealth Management LLC Sells 1,384 Shares of SPDR S&P Biotech ETF $XBI

Modera Wealth Management LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,396 shares of the exchange traded fund’s stock after selling 1,384 shares during the quarter. Modera Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,774,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 625.1% during the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after purchasing an additional 12,344,558 shares in the last quarter. Goldman Sachs Group Inc. raised its position in SPDR S&P Biotech ETF by 33.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after purchasing an additional 3,353,029 shares during the last quarter. Simplex Trading LLC lifted its holdings in SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after buying an additional 1,741,445 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth $85,155,000. Finally, Meitav Investment House Ltd. boosted its position in SPDR S&P Biotech ETF by 2,199.6% in the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock valued at $33,229,000 after buying an additional 383,040 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $108.96 on Friday. The stock has a market capitalization of $6.61 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $113.21. The stock has a fifty day moving average of $102.21 and a 200-day moving average of $90.42.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.